Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05855434

The ACDC Study Assessing Cognitive Deterioration in COVID-19

Sponsor: NHS Grampian

View on ClinicalTrials.gov

Summary

The long-term impact and effects of COVID-19 are still being determined. However, what is clear, is that some people are still struggling following a period of illness with COVID-19. Now known as 'long covid' or 'post covid-19 syndrome', people are not only experiencing physical symptoms like fatigue and breathlessness, but also psychological difficulties, as well as cognitive changes often referred to as 'brain fog'. This can include symptoms, such as changes in memory, difficulties with organisation and problem solving, as well as the ability to concentrate. Evidence from other research areas suggest that these changes could be due to shrinkage in areas of the brain that control functions like memory and concentration. There are also connections between different brain areas that work together to perform tasks such as remembering and concentrating, and these areas may also be affected by COVID-19. The purpose of this study is to scan the brains of patients reporting cognitive changes having been hospitalised with COVID-19 infection to see if any of these areas or connections have changed after infection and whether this might explain these cognitive changes.

Official title: Assessing Cognitive Deterioration in COVID-19 (ACDC) Cognitive Impairment After COVID-19 - Inflammatory and Neural Correlates: A Pilot Study

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

OBSERVATIONAL

Enrollment

30

Start Date

2023-01-01

Completion Date

2024-07-16

Last Updated

2026-06-08

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Magnetic Resonance Imaging

Magnetic Resonance Imaging/Magnetic Resonance Spectroscopy

Locations (1)

Aberdeen Royal Infirmary

Aberdeen, Grampian, United Kingdom